Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Ascendis Pharma A/S (Nasdaq: ASND)

Ascendis Pharma is an emerging pharmaceutical company which is creating improved, patentable versions of both currently marketed drugs and high-value development-stage opportunities. The company is built upon a novel transient linker technology, which conjugates peptides, proteins and small molecules to a carrier molecule in a reversible fashion. This unique reversibility allows an unmodified active drug to be released (unlinked) in the body in a precise, time-controlled fashion, creating a long-acting effect. Conventional conjugation technologies are unable to achieve this type of slow-release mechanism because the polymer cannot de-link from the drug.

Ascendis’ commercial headquarters is based in Copenhagen, Denmark. Its research organization, formerly known as Complex Biosystems, is located in Heidelberg, Germany. The expertise at the two sites creates a continuum from discovery to clinical development and commercialization that facilitates rapid product development. *

 

Period Start 2007-12-01 established
  Group Ascendis Pharma (Group)
  Today Ascendis Pharma (Group)
Products Industry TransCon technology
  Industry 2 pharmaceutical
Persons Person Mikkelsen, Jan (Ascendis Pharma 201609 CEO)
  Person 2 Smith, Scott T. (Ascendis Pharma 201609 CFO)
     
Region Region Hellerup
  Country Denmark
  Street 12 Tuborg Boulevard
  City 2900 Hellerup
  Tel +45-3694-4486
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2017-12-31)
  Currency EUR
  Annual sales 1,530,000 (revenue, consolidated (2017) 2017-12-31)
  Profit -123,897,000 (2017-12-31)
  Cash 690,400,000 (2019-06-30)
     
    * Document for »About Section«: 
     
   
Record changed: 2024-02-12

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Ascendis Pharma (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top